Company intelligence / Profile preview

BESO

Walnut, California, USA

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Beso Biological Research is a California-based biotechnology company specializing in the research and development of botanical-derived therapeutic agents. The company is primarily known for its lead candidate, Beso-1, a proprietary herbal formulation that has been evaluated in clinical trials for the treatment of COVID-19 and is being explored for oncological and anti-inflammatory applications. Beso Bio aims to bridge the gap between traditional medicine and modern pharmacology through rigorous scientific testing and standardized manufacturing processes. Their portfolio includes both potential prescription drugs and high-end nutritional supplements designed to support immune health.

Therapeutic areas: OncologyImmunologyInfectious Diseases
Modalities: Botanical drugNatural products
Industry: Biotech

Beyond the preview

Go deeper on BESO.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BESO.

Explore the full profile